Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Compassion and Association: Building Significant Connections - 2NASA's Perseverance Mars rover could break the record for miles driven on another planet
- 3UK forecast to face weaker growth and higher inflation from Iran war
- 4Instructions to Expand Your Advantages from an Open Record Reward
- 5Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick'
- Top 15 Online Entertainment Stages for Individual Marking
- How a Middle East War Becomes a Retail Price Hike
- Hot Electric Vehicles for 2023
- Without evidence, CDC changes messaging on vaccines and autism
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
- Step by step instructions to Integrate Lab Precious stones into Special Adornments Pieces
- Kate Hudson, 46, says she doesn't need long workouts to feel good
- Ancient mass grave discovered in water cistern during Tel Azekah excavations
- ‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
